Stay updated on Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page footer revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a website release/version change rather than a change to the displayed clinical trial information.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision: v3.5.2 replaces the previous Revision: v3.5.0 on the page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No study data, eligibility criteria, or outcomes were altered.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing the previous v3.4.0 label.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.